logo

For the Inventor, By the Inventor

Grayslake, IL, United States of America

Alan X Wang

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Abbott Laboratories Corporation, Ligand Pharmaceuticals, Inc., Other. Active years: 2000-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alan X Wang. Retrieved from https://idiyas.com/inventor/alan-x-wang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 6.4

ph-index = 2

Forward Citations = 58(Granted Patents)


Location History:

  • Guilford, CT (US) (2000 - 2003)
  • Grayslake, IL (US) (2005)

Company Filing History:

goldMedal2 out of 4,190 
 
Abbott Laboratories Corporation
 patents
silverMedal1 out of 139 
 
Ligand Pharmaceuticals, Inc.
 patents
bronzeMedal1 out of 834,601 
Other
 patents
where one patent can have more than one assignee

Years Active: 2000-2005

Loading Chart...
3 patents (USPTO):Explore Patents
1. 6951942 - Glucocorticoid-selective anti-inflammatory agents (2005-10-04),
2. 6506766 - Glucocortiocoid-selective antinflammatory agents (2003-01-14),
3. 6166013 - Glucocortiocoid-selective agents (2000-12-26),

Title: Alan X Wang: Innovator in Anti-Inflammatory Agents

Introduction

Alan X Wang is a notable inventor based in Grayslake, IL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory agents. With a total of 3 patents to his name, Wang's work has the potential to impact the treatment of various immune and autoimmune diseases.

Latest Patents

One of Wang's latest patents focuses on glucocorticoid-selective anti-inflammatory agents. These compounds, described by Formula I, are designed to partially or fully antagonize, repress, agonize, or modulate the glucocorticoid receptor. This innovation aims to treat immune, autoimmune, and inflammatory diseases in mammals. Additionally, the patent discloses pharmaceutical compositions that include these compounds and methods for inhibiting immune or autoimmune diseases.

Career Highlights

Throughout his career, Alan X Wang has worked with prominent organizations, including Abbott Laboratories Corporation. His experience in the pharmaceutical industry has equipped him with the knowledge and skills necessary to innovate in the field of anti-inflammatory treatments.

Collaborations

Wang has collaborated with several professionals in his field, including Michael J Coghlan and Todd Kevin Jones. These partnerships have likely contributed to the success of his inventions and patents.

Conclusion

Alan X Wang is a distinguished inventor whose work in glucocorticoid-selective anti-inflammatory agents showcases his commitment to advancing medical science. His contributions have the potential to improve the lives of many individuals suffering from immune and autoimmune diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…